Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
1038 participants
INTERVENTIONAL
2026-01-01
2027-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Randomized Experiment of Sleep Technology
NCT04246424
Efficacy of a Novel Sleep Intervention in Short Sleepers
NCT04697680
Effects of Sleep Hygiene Education on Sleep Health in Community-Dwelling Older Adults
NCT05483920
Effects of Sleep Hygiene Education on Sleep Health in Adults Ages 50-80
NCT06129045
hiSG Sleep Health Study
NCT04878380
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
The control group receives standard feedback, where they will be asked to maintain a consistent sleep schedule irrespective of what the Fitbit data or sleep diary report.
No interventions assigned to this group
Intervention: Sleep Diary
This arm receives weekly feedback on their sleep schedule based on sleep diary data.
Sleep Diary
Based on the participant's sleep diary data, a new weekly sleep schedule will be prescribed as follows: if sleep efficiency is \<85%, the prescribed time in bed is reduced by 15 minutes (reducing sleep opportunity by 15 minutes); if sleep efficiency is 85-90%, the schedule remains unchanged; if sleep efficiency is \>90%, the prescribed time in bed is increased by 15 minutes, allowing an extra 15 minutes of sleep opportunity.
Intervention: Fitbit
This arm receives weekly feedback on their sleep schedule based on Fitbit data.
Fitbit
Based on the participant's Fitbit data, a new weekly sleep schedule will be prescribed as follows: if sleep efficiency is \<85%, the prescribed time in bed is reduced by 15 minutes (reducing sleep opportunity by 15 minutes); if sleep efficiency is 85-90%, the schedule remains unchanged; if sleep efficiency is \>90%, the prescribed time in bed is increased by 15 minutes, allowing an extra 15 minutes of sleep opportunity.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sleep Diary
Based on the participant's sleep diary data, a new weekly sleep schedule will be prescribed as follows: if sleep efficiency is \<85%, the prescribed time in bed is reduced by 15 minutes (reducing sleep opportunity by 15 minutes); if sleep efficiency is 85-90%, the schedule remains unchanged; if sleep efficiency is \>90%, the prescribed time in bed is increased by 15 minutes, allowing an extra 15 minutes of sleep opportunity.
Fitbit
Based on the participant's Fitbit data, a new weekly sleep schedule will be prescribed as follows: if sleep efficiency is \<85%, the prescribed time in bed is reduced by 15 minutes (reducing sleep opportunity by 15 minutes); if sleep efficiency is 85-90%, the schedule remains unchanged; if sleep efficiency is \>90%, the prescribed time in bed is increased by 15 minutes, allowing an extra 15 minutes of sleep opportunity.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Have a typical sleep schedule of \<=6 hours per night
3. Must have a FitBit device (any model) with Heart Rate Monitor
4. Must have bedtime between 8 pm and 1 am
5. Must have a waketime between 5 am and 10 am
6. Must not have insomnia as determined by diagnosis or score on the Insomnia Severity Index (ISI), or must be treated.
7. Must not have sleep apnea as determined by diagnosis or STOP-BANG scale, or must be treated.
8. Must have a computer or smartphone device for daily sleep diaries.
9. Must have an initial sleep efficiency of at least 85% as determined by sleep diaries and actigraphy.
Exclusion Criteria
2. Participant is under 18 years of age or older than 60 years of age
3. Does not own a FitBit device with Heart Rate Monitor
4. Sleep \>6 hours per night.
5. Typical bedtime before 8 pm or after 1 am
6. Typical waketime before 5 am or after 10 am
7. Diagnosed with sleep disorders including insomnia or sleep apnea
8. Diagnosed mental health disorder which may impact sleep (i.e. Bipolar Disorder)
9. Taking medications that may affect sleep.
10. Baseline sleep efficiency less than 85%.
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Arizona
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
MICHAEL A GRANDNER
Associate Professor of Psychiatry
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael A Grandner, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Arizona
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Arizona
Tucson, Arizona, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2008934275
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.